Effects of Switching From Oral to Transdermal or Transvaginal Contraception on Markers of Thrombosis

Contraception - United States
doi 10.1016/j.contraception.2008.07.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Oral Contraception and Thrombosis

BMJ
1965English

Comparison of the Effects of Transdermal and Oral Rivastigmine on Cognitive Function and EEG Markers in Patients With Alzheimer’s Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2014English

Hormonal Contraception and Thrombosis

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2016English

Effects of Progestogen Oral Contraception With Norethisterone on Blood Clotting and Platelets

Obstetrical and Gynecological Survey
MedicineGynecologyObstetrics
1973English

Real-World Analysis of Switching Patients With Schizophrenia From Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate

Drugs - Real World Outcomes
Pharmacology
2019English

Complications of Oral Contraception

BMJ
1965English

Venous Thrombosis in Users of Non-Oral Hormonal Contraception: Follow-Up Study, Denmark 2001-10

British Medical Journal
Medicine
2012English

Comparative Pharmacokinetic Profile of Aceclofenac From Oral and Transdermal Application

Journal of Bioequivalence & Bioavailability
2009English

Erratum To: Effects on Bone Metabolism Markers and Arterial Stiffness by Switching to Rivaroxaban From Warfarin in Patients With Atrial Fibrillation

Heart and Vessels
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy